Charles River Laboratories Adds Nancy C. Andrews, M.D., Ph.D., to Board of Directors
Charles River Laboratories International, Inc. (CRL)
Last charles river laboratories international, inc. earnings: 2/11 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.criver.com
Company Research
Source: Business Wire
WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of Nancy C. Andrews, M.D., Ph.D., to its Board of Directors, effective February 28, 2020. Dr. Andrews is Duke University’s Dean Emerita of its School of Medicine, Vice Chancellor Emerita for Academic Affairs, and Professor of Pediatrics, Pharmacology, and Cancer Biology. She is also on the Board of Directors of Novartis AG. Dr. Andrews’s extensive experience as a physician, scientist, professor, and senior administrator at leading academic institutions and hospitals will enhance the scientific leadership of Charles River’s Board of Directors. As a member of the Board, she will serve on the Science and Technology Committee and the Corporate Governance and Nominating Committee.“Dr. Nancy Andrews is an accomplished administrator, educator, and researcher. Her experience overseeing prominent scientific research organizations will provide a unique client perspe
Show less
Read more
Impact Snapshot
Event Time:
CRL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRL alerts
High impacting Charles River Laboratories International, Inc. news events
Weekly update
A roundup of the hottest topics
CRL
News
- Bioburden Testing Market Analysis Report 2024-2030: Outsourcing Surge Boosts Bioburden Testing Services as CMOs Expand Globally [Yahoo! Finance]Yahoo! Finance
- EW Healthcare Partners Announces Leadership Evolution [Yahoo! Finance]Yahoo! Finance
- Charles River Laboratories International, Inc. (NYSE: CRL) was downgraded by analysts at CLSA from a "hold" rating to an "underperform" rating. They now have a $164.00 price target on the stock.MarketBeat
- Sterility Testing Market Valuation Set to Worth Over US$ 2,945.74 Million By 2032 | Membrane Filtration Test to Remain the Most Prominent and Highly Preferred Says Astute Analytica [Yahoo! Finance]Yahoo! Finance
- Insight into Murray Stahl's Strategic Moves: A Focus on Bitcoin Trust and Digital Assets [Yahoo! Finance]Yahoo! Finance
CRL
Earnings
- 11/6/24 - Beat
CRL
Sec Filings
- 11/12/24 - Form 4
- 11/12/24 - Form 4
- 11/8/24 - Form 4
- CRL's page on the SEC website